Read + Share
O'Reilly EM. Flashback Foreword: Bevacizumab and FOLFOX4 for Colorectal Cancer and Bevacizumab
Versus Placebo Plus Oxaliplatin-Based Chemotherapy in Metastatic Colorectal
Cancer. J Clin Oncol 2023;41:3661-3662.
PMID: 37459753
|
 |
|
O'Reilly EM. Flashback Foreword: Bevacizumab and FOLFOX4 for Colorectal Cancer and Bevacizumab
Versus Placebo Plus Oxaliplatin-Based Chemotherapy in Metastatic Colorectal
Cancer. J Clin Oncol 2023;41:3661-3662.
PMID: 37459753
|
|
|
|